Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion
Annals of Rheumatic Diseases, 02/16/09
Hou Y et al. – Junctional adhesion molecule A (JAM-A) expression is dysregulated in systemic sclerosis (SSc) skin. Its decreased expression on endothelial cells may result in a reduced response to proangiogenic bFGF, while increased expression on fibroblasts may serve to retain myeloid cells, which in turn secrete angiogenic factors.
Methods- Study to investigate the role of JAM-A in pathogenesis of SSc
- Biopsies obtained from proximal and distal arm skin; serum obtained from pts and normal (NL) volunteers
- Cell surface ELISAs and immunohistology were performed
- An ELISA was designed to determine the amount of soluble JAM-A (sJAM-A) in serum
- Myeloid U937 cell-SSc dermal fibroblast and skin adhesion assays were performed to determine the role of JAM-A in myeloid cell adhesion
- Stratum granulosum and dermal endothelial cells (ECs) from distal arm SSc skin exhibited decreased expression of JAM-A vs NL
- sJAM-A was elevated in the serum of pts with SSc
- Conversely, JAM-A was increased on the surface of SSc vs NL dermal fibroblasts
- JAM-A accounted for a significant portion of U937 binding to SSc dermal fibroblasts
- In addition, JAM-A contributed to U937 adhesion to both distal and proximal SSc skin
Related Articles
Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: A cross-sectional study
Journal of Rheumatology, 11/18/09
Relevance Score: 88%
Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus
Rheumatology International, 11/16/09
Relevance Score: 88%
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4
Arthritis & Rheumatism, 11/09/09
Relevance Score: 88%
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians
Annals of Rheumatic Diseases, 10/23/09
Relevance Score: 87%
What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort - Results from the Canadian Scleroderma Research Group (CSRG)
Rheumatology International, 10/02/09
Relevance Score: 79%
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Rheumatic heart disease and its control in the Pacific
Expert Review of Cardiovascular Therapy , 12/15/09
Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature
Seminars in Arthritis and Rheumatism, 12/15/09
Heart rate turbulence assessment in systemic sclerosis: The role for the detection of cardiac autonomic nervous system dysfunction
Rheumatology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


